Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Eye See

Eye See artwork

Vortex: Innovation, Precision & the Future of Retinal Surgery

Sep 19, 202634 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Send us Fan Mail 👁️ EYE SEE PODCAST | Innovation at the Surgeon’s Fingertips What does it take to turn a surgeon’s idea into an innovation that can make a difference in the operating room? In this episode of the Eye See Podcast, we sit down with Michael Fanning, CEO of Vortex Surgical, and Beth Brauer - their Regional Sales Manager to explore the world of ophthalmic surgical innovation and the evolving landscape of vitreoretinal surgery. Michael shares his perspective on how Vortex Surgical works alongside ophthalmic surgeons to identify challenges, develop practical solutions, and create precision surgical instruments designed around the needs of the surgeon. We discuss: 🔹 The story and vision behind Vortex Surgical 🔹 Innovation in vitreoretinal surgery 🔹 The importance of precision, control, and surgical instrumentation 🔹 How surgeon feedback drives product development 🔹 The journey from an idea to a medical device used in the operating room 🔹 The role of technology in advancing retinal surgery 🔹 Expanding access to innovative ophthalmic technology globally 🔹 What the future may hold for retinal surgery and ophthalmology 🔹 Advice for the next generation of medical-device innovators From the smallest surgical instrument to the biggest technological breakthrough, innovation ultimately has one goal: helping surgeons provide better care for their patients. 🎙️ Join us for an insightful conversation with Michael Fanning of Vortex Surgical on the future of ophthalmic surgical innovation. ▶️ Watch the full episode and discover how innovation is changing the way we approach retinal surgery. #EyeSeePodcast #VortexSurgical #MichaelFanning #Ophthalmology #Retina #RetinalSurgery #VitreoretinalSurgery #OphthalmicSurgery #MedicalDevices #MedTech #SurgicalInnovation #HealthcareInnovation #EyeCare #VisionCare Graceful Movement Support the show

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

SPEAKER_01Welcome back to IC Podcast, and today we're exploring the world of atomic surgical innovation, particularly the technology and instruments that help retinal surgeons perform some of the most delicate procedures in medicine. I'm very pleased to welcome Beth Brower, Regional Sales Manager of Vortex Surgical, and of course Mr. Mike Fanning, the esteemed CEO of Vortex Surgical. Beth and Mike, welcome to IC Podcast. It's great to have you with us.

SPEAKER_02So great to see you, Dr. Ross.

SPEAKER_00Dr. Ross, how are you? Good morning. I'm wonderful and I'm excited to host you guys. We were just talking about how long I've been working with Beth. And we've been excited to work with uh just great innovators that are sharing and learning. And that's how I've known Beth in that capacity. We've always been tag teaming, and what do we know? What can we learn? How can we make a patient's case go better? So now we're taking it a little bigger because these are a little bit volatile times, and we're recognizing that there's few family-based companies or family-based practices.

SPEAKER_00Solo practices going by the wayside because of private equity. So we wanted to engage uh someone who, when we had zero patients out here in Arizona, I've known Beth in two states now. Uh, you were guys were the first group that gave us a few starter kits before we got patients, and that really was a great help because we're burning through cash and we don't have any patients. So your support was really helpful. And now we're entering a new era where because of PE and we're seeing the lack of investment in capital and operating rooms, we're building our own in-office operating room, and we're seeing that trajectory go from hospital-based surgery to hospital outpatient-based surgery to ambulatory surgery centers, 80% of which are owned by PE now.

SPEAKER_00And now the trend toward in-office operating rooms where we control when we can do cases, how we can do cases, and transitioning our office staff into the operating room to try to improve safety and quality. So I've come back because I noticed that one of your mission states was was never silent. And so we've been outspoken that we need to continue giving uh great care. So I wanted to start with uh how did you get founded and why was that a critical part of your mission statement?

SPEAKER_03Yeah, so uh Dr. Ross, thank you. And Hazel, thanks for hosting uh Beth and I uh today. And we are thrilled to be here and a longtime supporter of you and your mission and and uh everything you're doing to help expand education, training uh throughout the world uh for ophthalmology. So thank you for your efforts as well. So um really uh Vortex Surgical, fairly humble uh story, truthfully, uh founded in 2016 uh by a collection of former employees uh at a company that was purchased by Boston Lawn.

SPEAKER_03And we uh you know, we started with uh one employee in St. Charles, Chesterfield, Missouri. And uh as we sit here today, we're at almost 60 employees. Um but really um the origin of that group is that we had spent our careers fundamentally designing and developing specialized instrumentation for surgical retina. And we kept running into the same structural problem, and that is that retina is uh is a very small and, as you know, deeply specialized field uh that is served in most part by very, very large companies, large organizations, and for perfectly rational reasons, you know, that they design for the average case in the widest marketplace, and frankly, they shouldn't be ashamed for that because that's how you scale a business.

SPEAKER_03Um, but a retina surgeon, in our opinion, isn't working on an average case, they're working on this detachment in this eye with this anatomy on this particular patient. And, you know, it's quite possible that the instrument in their hand at that particular point in time is a compromise somebody may have made in a boardroom or a conference room several years prior. And so our focus is surgeon and patient intimacy as much as we can.

SPEAKER_03We work very, very closely with surgeons, uh much like yourself, who are innovators, leaders in forward thinking, and we look to partner with them to turn their concepts and thoughts and ideas uh into products. So our vision has never been to become a big company. Uh, it is to be a company that a retina surgeon could reach out to where the person who picks up the phone um can get a prototype made, and a good idea doesn't have to clear four committees uh before anyone tries it.

SPEAKER_03And you know, everything else we've built, the engineering team, the clean room, the quality systems, the partnerships exist to make that possible at a level uh of and vigor, a vigor than an operating room and we feel the patients deserve.

SPEAKER_00So I think that's a great question. I think that's a great answer. And as I look to the future, when we decided to build this in-office operating room, we went with IOR partners, also in your neck of the woods, and they said, Well, you have to have a lot of volume to make your purchase of building the IOR, et cetera. I said, that's not what we're about. We're about, I've had four patients with retinal detachments this year that had to wait five days to get into an operating room. And that is really heartbreaking for me as a great surgeon who knows I can fix it.

SPEAKER_00So we ended up, you know, doing an in-office pneumatic retinopixie when they were an ideal candidate and having them, you know, literally stand on their head almost while we waited for an operating room. And that's when I decided that all my decisions in my career have been based on those patients and the trajectory, even though four patients isn't a lot and it seems like a big expense to endure. But I noticed that doctors coming from overseas said they were profoundly impacted by your tools.

SPEAKER_00And as they practiced with them in the Sim Center, they said, where did these come from? And then I heard a talk on 2050, one of four four peoples demographically in the world will be in Africa. So it dawned on me that we're not really thinking about who's going to be the next group of surgeons dealing with thousands and millions of people. And I thought that your products, it really would stand the test of time because the concept is to tailor them to the pathology, the patient population, and I'm noticing a change.

SPEAKER_00So um patients want to know individual things now, like what operating room, what kind of equipment, what are you using, who do you partner with? And I see them getting more granular. So I think it's pretty exciting. Uh Vortex's mission, and I just wanted to highlight how long you guys have been supporting. I think when you were under another company, you gave us the first surgical instruments to go to Brazil, and we took those to northern Brazil, and I think they're still using some of them. They took great care of them, but uh we hand carried them in and walked, walked them through uh customs.

SPEAKER_00And I said, How am I gonna get a vitrector, uh a hundred IOLs and all this through? And someone said to me, Unfortunately, you're gonna have to look for the obnoxious person on the plane and get right behind them in customs and just put them in a dirty duffel and walk them through. And so all of them got through customs, but you guys were the ones that sent us all the non-disposable instruments that were cared for and used in northern Brazil. So as I see the times changing, I want to thank you for all the things you're doing.

SPEAKER_00Um, I'm gonna talk about your um convenience kits and your in-office uh kits because I've seen a lot of endophthalmitis in the last two years. And I always tell patients that we're using, you know, sterile kits that are disposable, but we're not trying to re-sterilize these during a time when there's a decrease in human resources. We're all having difficulty uh getting great staff. And so when you see a change where there's more volume needed to break even, and you see uh less people staying long term at individual practices, there's room for safety problems, meaning, uh, how do you know that the autoclave is being worked appropriately?

SPEAKER_00So I think those convenience kits are very important because we know that we're not worrying about did someone sterilize them correctly. And so I want to highlight that that's a unique feature of Vortex and those kits are very reasonably priced. Um, but when doctors are thinking about margins, some of them are making shortcuts. I'm seeing more videos of intravitual injections with people not wearing gloves. I'm seeing more videos, and I'm thinking, are you really gonna post that? So I want to highlight that we've always partnered with people that are pro focused on safety and innovation.

SPEAKER_00Same thing with your convenience kits. I don't know if you've been thinking about how doctors transitioning to in-office operating rooms are going to keep the number of purchases uh going forward to make it less less costly to the patients in their quote unquote facility.

SPEAKER_02I wanted to just add a comment along the lines of the convenience kits. We're also noticing that the um surgical tech who has been with a retina surgeon, you know, for 20 years, we're not seeing that model any longer. There's been a lot of turnover in surgery centers and hospitals with the with the staff and the level of training. And so to be able to say to somebody who might be newer to retina surgery or vitrectomy surgery, you know, just go pull that kit over there. It doesn't, it, it doesn't matter what what uh the peel requires.

SPEAKER_02Everything is in the kit. And so it's taking one level of decision making away. And it's also, I think, upping everybody's skill level. If everyone's on the same page for these three cases, we're gonna pull these kits. Um, if you wouldn't mind, I you touched on something else I wanted to add a comment about. You were talking about looking at office-based vitrectomy or doing more in the office for surgical procedures. The nice thing about vortex surgical, if um I could offer up our small humble brag, is that with experience, you get the opportunity to step in and see uh see a problem.

SPEAKER_02And with our experience, we can offer more solutions. And so I can speak to Mike Fanning and I being involved with in um some early in-office vitrectomies dating back to 2014. And so that's experience that we can bring with any retina surgery surgery group that's interested in, let's say, changing the model for surgery, um, or maybe like adding something that's a little bit more flexible. Um and so vortex surgical are really we we have a number of goals per se, but we really want to meet the retina surgeon where they're at.

SPEAKER_02So, whatever your patient surgical goals are, there are patient surgical goals. And so we hope that every retina surgeon that we work with, they can draw on our experiences and tell us like what the challenge is. And to Mike's point earlier, we we we're our our our bench is not that deep. So there's not there, I mean, today for the call, you have the CEO of Vortex Surgical and myself a regional sales manager. And so, and I know by the way, my boss is the CEO. That's that's a whole other level of pressure.

SPEAKER_02But um so yeah, you touched on uh being flexible with the procedures and and then the convenience kits. So I think that's something that Vortex Surgical as a smaller company can address for retina surgeons.

SPEAKER_00No, we plan to partner with you guys for the convenience kits because I'm seeing uh symbiosis in a way of decreasing uh the stress that the staff has as they transition from the clinic to the operating room. And I think they're gonna be more diligent because they know the patients. So there's decreased anesthesia risk and there's increased safety. But adding to it that we're just opening this kit and putting the pack in is gonna be wonderful. So that I'm I'm noticing the efficiency.

SPEAKER_00Um, I myself have gone through six vitrior retinal techs that I've had to train in the last year. And as you know, having that same consistency increases efficiency, decreased OR time, and patients have better outcomes. So I think it's very exciting what you guys are doing. You guys are a concierge uh retina equipment team. That's how I'm thinking of you. And we're partnering with concierge. And I know Hazel had a question as to how go ahead, Hazel. I don't want to interrupt you.

SPEAKER_01Oh, yes. Um, as we discussed earlier, and as Dr. Ross had mentioned, I think one of the things that stands out about Vortex is the focus on surgeon-driven innovations. How important is direct feedback from retinal surgeons when you're developing a new product?

SPEAKER_03Um, happy to take that, uh, Beth. So this is truly one of the real advantages of a small company. And I don't want to be cute or curt about it. Uh large organizations, our experience, because we've worked for them in the past, uh, typically run voice of customer analysis, uh sometimes on a calendar basis, structured advisory boards, quarterly cycles, a roadmap for product development that can be sometimes as much as a year uh out in advance.

SPEAKER_03As I mentioned earlier, we can take a call on Tuesday and have something in the surgeon's hands within a very, very short period of time. That's not a process improvement. That's a different category of relationship. And I think Dr. Ross, you kind of touched on that a little bit earlier. We just look at things and we've tried to from our very early days to just look at the intimacy that I referred to earlier. Uh, and we really do take that to heart. Um, the thing I would I would tell anybody doing this is that surgeons almost never hand you a specification, right?

SPEAKER_03Um, what they hand you is a workaround. And what I mean by that is you'll ask them and they'll say, you know, the case went fine, and then you watch, uh, and maybe they just curved something or bet something in the surgical field. Or they've used an instrument for a job. I see you smiling, Dr. Ross. Um, or you see them using an instrument maybe for a job it wasn't initially designed for, or they've switched hands, right? Just nuances. Pay attention to see what's going on in the operating room.

SPEAKER_03And really, what I find is that the the question that unlocks uh most things is not what do you need? Okay. It's what did you do instead? What was your workaround? And the workaround is the unmet need. And it's probably already solved poorly by the workaround. And our job is to try to partner with that surgeon to hear their feedback. And again, Hazel, to your point, it's not always direct, it's sometimes indirect feedback that you take by being observant in the operating room, picking up on cues, and then asking the right questions because it's in there.

SPEAKER_03The problem is in there, it may not be obvious, and we have to come uh to the same conclusion with uh with the surgeon. Um and and and I'll tell you that it it's really about discipline and truly about discipline is separating a surgeon's preference from something that may be generalizable. Great surgeons have strong hands, oftentimes strong opinions, and not every strong opinion may be a product.

SPEAKER_03And and that sometimes is a hard reality. And it doesn't mean it's not a great idea, um, but we put things into trial. We try with the surgeon ideas, once we've collaborated and figure out what their workarounds are, we try to put the products into trial early for exactly that reason. I'd much rather, I think we would much rather be told uh during a wet lab or very, very early prototypes uh than to find out in a wet lab that this product is a good idea, but it's not serving an enormous opportunity.

SPEAKER_03Then we can make the judgment, as we have done with a number of products that we've provided to the surgical market, because there was no feasible alternative to meet that clinical need.

SPEAKER_00And that requires the powers of clinical observation. So when you guys are coming into the operating room, you're really looking and observing, um, which is not seen very much today. So I want to compliment you there. I'm gonna circle back to your team developed the first in-office vitrector back uh because I know that I met with Beth and we were going to implement it in our office in Grand Blanc, Michigan, because we noticed there was a difficulty, even though I could call and say I have a detached retina, and they'd say, come at five.

SPEAKER_00Not everybody had that ability. And so and many of my patients started having hired deductibles. So going to a surgery center meant surgeon fee, anesthesia fee, and a um pretty high surgical hospital facility fee. So that was starting back in 2013. That's when I engaged Beth for in-office surgery. So it hasn't changed, just the deductibles have gone skyrocket high, and the access has gone down, and the expertise of the staff in the operating room has gone down.

SPEAKER_00So uh you'll be the uh go-to for in-office surgery equipment moving forward. Um, do all your pieces of equipment uh tie into the major vitrectors right now? The light the lasers, et cetera. Go ahead.

SPEAKER_02Yeah, thank you for that question. Because um I'll take it. So, yes, our laser probes are fully compatible with all of the vitrectomy machines. Um, our forceps are handheld instruments, so it really is irrelevant which platform that you're using. Um, a small thing that when Mike was um looking at the product platform goals early on, we were looking to his point where the doctors were doing workarounds. And the first product that we came out with were soft tips. And before the Vortex soft tip was launched, um, doctors were either trimming the tips to make them shorter because they were not passing through the valves easily.

SPEAKER_02I've heard stories of where they have to turn the room lights on, they have to get the tech involved. If the scissors trimming the soft tips aren't sharp, they're gonna have a messy soft tip. And so Mike and our early engineers were like, let us come up with a soft tip that just without thinking and in a length of one millimeter length. So, you know, because a lot of times you have to drain subretinal fluid, so why should you have to compromise that length? So they made our soft tips with slightly stiffer silicone that pass very easily through the valves.

SPEAKER_02And it's like a small thing within the engineering. So I know your question was do our equipment work with everything? Yes. Our equipment, laser probes work with all the machine platforms. Yes, we're fully compatible with all the machine platforms, and we are always trying to put a small improvement in the device. Um, our forceps, we came out with the tail and line of forceps. And so what we did is we improved the um visualization where you're working because a lot of surgeons now are working with heads up 3D systems.

SPEAKER_02So they have a wider angle view, they have great illumination, they can really see the tips where they're working with those forceps. Oh, but a lot of forceps haven't been uh re-engineered or developed for 10 or 15 years and the soft and the tips are bulky. So where you're going to peel that one micron membrane, do you have metal, yeah, surgical stainless steel in the way? So we came out with the tail and line of forceps. So I I realize I kind of um expanded on your question, but um, yes, we work with all the platforms and we're always looking to make things, make the surgical experience more comfortable for the retina surgeon so they can more easily obtain their surgical goals.

SPEAKER_00That's that's awesome. Thank you for uh elaborating there. Um in the next five years, as we move to gene therapy potentially and a new delivery of medication that could be submacular, are you innovating for that future?

SPEAKER_03Uh we absolutely are. As we look to the short and midterm future, that those are subchroidal, subretinal, macular. I mean, the the the ability to deliver precise volumes to very specific areas without egress is a challenge I think a lot of companies are chasing right now. Um we have already designed and developed a number of products in collaboration with surgeons that have have helped us leapfrog a lot of what has been available in the market, and we continue to work on a very robust RD pipeline that continues to address those specific therapeutic challenges.

SPEAKER_00Well, I noticed that you've also tackled ocular oncology and you've developed a light box. Can you tell us a little bit about that light box? Because we used to use the old greasehopper light box that was the became the chandelier system for uh more complex uh peripheral retinal pathology. Can that light box that's used for That's LED based. Can that be used for a chandelier system?

SPEAKER_02I can take this question. The LED light, unfortunately, is not bright enough for a chandelier. However, you touched on ocular oncology. Again, that's an example of vortex surgical. A retina oncologist approached us and said that there was an unmet need because the Myra boxes that were 40 years old in every OR were no longer being able to be serviced. And so we came up with transglerol illumination and pupil illumination for marking tumors for brachytherapy.

SPEAKER_02And then we also have the nanocannula that has a 41-gauge tip. And so you can insert it through a 27-gauge cannula to do an intraoperative posterior tumor biopsy. So we have a product for illuminating to mark tumors, and then a product for posterior tumor biopsies. But no, sadly, the light box, sorry, we do get that question a lot from international customers about chandelier illumination with the beacon, but the LED light is just not bright enough.

SPEAKER_00Do you guys have a vision board in Vortex?

SPEAKER_03Uh we don't. I think it resides in each one of our individually in each one of our heads, which is not a great leadership strategy, admittedly. Um but the but the but but the truth of the matter is we we're based in in St. Charles, as we mentioned. We've got a handful of people outside of the office. We are pretty aligned on what our annual and global strategies and um uh goals are. Um, but no, to uh to having a visual board. Uh no, but I will say that from an organizational perspective.

SPEAKER_03As a lot of manufacturing companies have, um, we do have um data boards built through our manufacturing processes where we can track things, but that's more on a task related as opposed to where we see ourselves in 10 days, 20 days, a year from now.

SPEAKER_00And my last question for you, uh, you partnered with CORSA, is that correct, in 2022? Can you tell me a little bit about that alignment and how it's benefited uh ophthalmologists that might be practicing in other countries outside the United States?

SPEAKER_03Uh, so a great question. Uh, as you point out, we've had a uh commercial relationship with uh CORSA ophthalmology for since 2022. Um, quite simply, we are a relatively small organization, right? From a distribution perspective. This is really about helping Vortex deliver our products from a commercial perspective to global operating rooms. And Corsa has a vast, vast, in the United States alone, they have a very robust distribution organization.

SPEAKER_03Uh in the US, as an example, uh, they will be on purchasing agreements that Vortex, because of our pure size being small, may not have access to. But because Corza has agreements with some of these large uh GPOs and purchasing groups, they can accelerate adoption of our products. Same thing internationally. They have Katina brands, uh, they have uh Aseco brands, they've got SharpPoint, they've got a number of different brands that they represent throughout the world.

SPEAKER_03Last told, I think it's 142 different countries they sell product into. And we are the beneficiaries of the relationships and the distribution channels they have established in many, many, many of those markets. So Corsa is is violently, and I use that word not to sound uh super aggressive, but they are violently committed to education. And they have a very, very uh large uh educational team. Uh they do wet labs globally, they do, and so they are the perfect partner for Vortex to permit us to get uh into Tanzania and other markets.

SPEAKER_03I mean, markets where we want other North Africa, uh all over the world, where we simply don't have the reach or the bandwidth at the current time to be able to do so. So we're grateful for Corza for what's been a wonderful relationship, and we look forward to continuing that for a number of years.

SPEAKER_00Well, thank you. Hazel's gonna finish with some rapid fire questions, and they're just brief answers, and we appreciate whoever can answer first. We'll take that. Go ahead, Casey. Yes.

SPEAKER_01All right. So I think I only have um four or five questions. Are you ready um for the questions, sir, Mike?

SPEAKER_03Let's go.

SPEAKER_01What has been the most rewarding part of your career?

SPEAKER_03Um waking up every day and realizing that I am surrounded by the industry's top people, professionals. I love going to work every day. Um the team we've assembled at Vortex is special to me. Um, not because we've worked for together for a combined almost 180 years, if we combine all of us. Um, but I really look around and as I look at the team that we've assembled, there's they're pros, pros.

SPEAKER_03I I couldn't be any more delighted and thrilled, including uh, you know, a family member. Uh so I I'm just I'm absolutely, I'm absolutely thrilled. Beth and I have spent 20 plus years working together. I don't see her, I mean, I see her as a as a colleague. And it really generally uh genuinely helps uh all of us become consistently aligned with what it is we're trying to execute on.

SPEAKER_01Next question, sir. That was a really great answer. But next question, what continues to excite you about ophthalmology and medical technology?

SPEAKER_03Um innovation is a word I think that's largely overused. Okay. And innovation from where I sit right now outside the operating operating room suite, I'm really curious to see how AI is going. And it's a there's another term that we hear a lot of. I I know there's a lot of work being done on the diagnostic side and even workflows and surgery and uh on the surgical side, but we're at a really interesting point, I think. You know, we've got digital operating rooms, we've got, you know, operating room equipment that's functioning largely like computers looking to integrate all this sort of stuff to help complete the treatment uh circle.

SPEAKER_03Um I'm really fascinated to see, and I may not be around long enough uh to see exactly how AI leans into this. No, no, but don't worry. Uh uh, but I may not be around long enough to see how AI genuinely impacts the surgical side of this. I know it's already having an impact in every other part of your functional departments uh in in the practices. So that's what I think I'm most interested and excited to see.

SPEAKER_01Another one, sir. What is one professional lesson that has stayed with you throughout your career?

SPEAKER_03Um always treat people with i uh so I hope you weren't looking for some exotic answer. Okay, and this really comes from my background and my upbringing, okay. Um is is people always m may not remember what you said, but they'll always remember how you made them feel. And I think um that's an important mantra and a uh a a little fight song that I kind of carry around in my mind.

SPEAKER_01I think I'm gonna carry that too, sir. And finally, last question. If you could see one major breakthrough in ophthalmology during your lifetime, what would you hope it would be?

SPEAKER_03Aaron Powell Big picture, uh elimination of blindness, restoration of sight.

SPEAKER_00That no one would have to wait to be repaired if they have a sight-threatening condition. And so many people do wait.

SPEAKER_01And if I may add, I think one of the most important takeaway from our discussion is that innovation doesn't always have to mean completely reinventing the way we do things. Sometimes it's about identifying a challenge that surgeons face every day and then finding a more precise, practical, and effective way to solve it. Um, Beth and Mike, thank you so much for joining us on IC Podcast. It has been a great pleasure having you here.

SPEAKER_03Thanks for hosting us. Thank you so very much.

SPEAKER_01And to everyone who is listening or watching, thank you for joining us today. Be sure to subscribe to IC Podcast for more conversations with the physicians, innovators, and leaders of shaping the future of ophthalmology. Until next time, keep an eye on the future.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Eye See Ep.10 : 2027 Medicare Changes?

    Oct 24, 20269 minAudio

    Send us Fan Mail Let's dive deep on some major Medicare changes for 2027 and how it will affect everyone. What happens when a physician evaluates a patient’s condition and performs a procedure during the same visit -...

    Credit the people on this episode

  2. Beyond the Blink: Rethinking Eyelid Function With OptiLift

    Oct 6, 202628 minAudio

    Send us Fan Mail What if the way your eyelids move could play a bigger role in eye health than we realize? In this episode of Eye See Podcast, we sit down with Dr. Robin Ross of Global Retina Institute for an in-depth...

    Credit the people on this episode

  3. Vision is More Than Just Eyesight

    Sep 26, 202639 minAudio

    Send us Fan Mail 👁️ VISION IS MORE THAN JUST EYESIGHT ✨ What does it really mean to see? In this episode of the Eye See Podcast, we sit down with Dr. Robin Ross for a meaningful conversation that goes beyond the eye...

    Credit the people on this episode

  4. Eye Floaters: When Should You Worry?

    Sep 17, 202635 minAudio

    Send us Fan Mail 👁️ EYE SEE PODCAST: EYE FLOATERS - WHEN SHOULD YOU WORRY? Have you ever noticed tiny black dots, squiggly lines, cobwebs, or shadows drifting across your vision? You may be experiencing eye floaters....

    Credit the people on this episode

  5. Beyond Dry Eye: Understanding Demodex, Blepharitis, and Modern Eye Care

    Sep 7, 202640 minAudio

    Send us Fan Mail Dry, burning, itchy, or watery eyes are symptoms many people experience - but could there be more behind them than simply “dry eyes”? In this episode, we take a closer look at the connection between Dry...

    Credit the people on this episode